Neal Walker, President and CEO at Aclaris Therapeutics, Inc. (ACRS), sold 66,520 shares at $21.51 ($1.4M) on 2021-06-02, disclosed to the SEC on 2021-06-02.
Open-market sale of $1.4M ACRS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.51 | 27,743 | $597K | 41.5% |
| 2 | $21.51 | 27,743 | $597K | 41.5% |
| 3 | $22.30 | 5,517 | $123K | 8.5% |
| 4 | $22.30 | 5,517 | $123K | 8.5% |
| Total | $21.64 avg | 66,520 | $1.4M | 100% |
| Filing → |
| ACRS | SELL | 2023-01-04 | $960K | — | Filing → |
| ACRS | SELL | 2022-04-25 | $1.1M | — | Filing → |
| ACRS | SELL | 2022-03-14 | $1.8M | — | Filing → |